June 6, 2008 Teleradiology lowers costs, increases efficiency of clinical trial Douglas Page -------------------------------------------------------------------------------- Teleradiology is playing a significant role in a major three-year international trial focused on sickle cell disease. The Silent Cerebral Infarct Multicenter Transfusion (SIT) Trial requires 1880 children with sickle cell disease from 28 pediatric clinical sites in the U.S., Canada, U.K., and France to undergo a screening MRI of the brain to detect the presence of silent cerebral infarct-like lesions. The patients also receive a prerandomized (baseline) brain MRI, as well as an exit MRI.
See full article and related articles at DiagnosticImaging.com
This article was republished with permission from CMPMedica, LLC
You need to be a member of radRounds Radiology Network to add comments!
Join radRounds Radiology Network